Prognostic Investigations of Expression Level of Two Genes FasL and Ki-67 as Independent Prognostic Markers of Human Retinoblastoma

被引:7
作者
Kouzegaran, Samaneh [1 ]
Shahraki, Kourosh [2 ]
Makateb, Ali [3 ]
Shahri, Farkhondeh [4 ]
Hatami, Negin [5 ]
Behnod, Vahid [6 ]
Tanha, Amir Saber [7 ]
机构
[1] Birjand Univ Med Sci, Fac Med, Dept Pediat, Birjand, Iran
[2] Zahedan Univ Med Sci, Alzahra Eye Hosp, Dept Ophthalmol, Zahedan, Iran
[3] AJA Univ Med Sci, Dept Ophthalmol, Tehran, Iran
[4] Zahedan Univ Med Sci, Sch Rehabil, Dept Optometry, Zahedan, Iran
[5] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA USA
[6] Baqiyatallah Univ Med Sci, Dept Mol Biol, Tehran, Iran
[7] Birjand Univ Med Sci, Fac Med, Dept Anesthesia, Moallem Ave,Behdarie Shahrestan, Birjand 97178, Iran
关键词
Retinoblastoma (RB); Ki-67 and FasL; Analysis; Expression; Molecular; CELL LUNG-CANCER; BREAST-CANCER; TUMOR-CELLS; LIGAND; APOPTOSIS; RESISTANCE; SYSTEM; MICE;
D O I
10.3727/096504016X14721217330657
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, expression of FasL and Ki-67 messenger RNA (FasL and Ki-67 mRNA) in human retinoblastoma (HRB) was examined by the immunohistochemistry method and quantitative real-time PCR. Positive expression of Ki-67 in tumor cells was detected in 16 of 30 patients (53.33%), and only 9 (30%) of the tissues from patients with retinoblastoma showed positive staining for FasL. Our results revealed that FasL expression was significantly higher in tumor tissue with invasion compared with the noninvasion form (p=0.033). Ki-67 expression was markedly increased in tumor tissues with invasion compared with the noninvasion group (p=0.04),but no significant correlation was found between FasL expression and differentiation (p>0.05). In addition, Ki-67 expression was strongly linked to differentiation (p<0.002). Expression of these FasL was correlated with shorter overall survival of patients, but its expression was not significantly associated with overall survival (p=0.15). The impact of Ki-67 expression on survival in patients was also evaluated. Ki-67 expression level was not found to be significantly associated with shorter survival (Kaplan-Meier; p=0.09). Univariate analysis revealed that massive choroidal invasion was correlated with poor prognosis. Taken together, the data suggest that massive choroidal invasion is also an important indicator of poor prognosis for HRB.
引用
收藏
页码:471 / 478
页数:8
相关论文
共 41 条
  • [1] Apoptosis Lumongga F., 2008, APOPTOSIS
  • [2] Fas ligand on tumor cells mediates inactivation of neutrophils
    Chen, YL
    Chen, SH
    Wang, JY
    Yang, BC
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (03) : 1183 - 1191
  • [3] GENERAL THEORY OF CARCINOGENESIS
    COMINGS, DE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (12) : 3324 - 3328
  • [4] Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer
    Delpech, Y.
    Wu, Y.
    Hess, K. R.
    Hsu, L.
    Ayers, M.
    Natowicz, R.
    Coutant, C.
    Rouzier, R.
    Barranger, E.
    Hortobagyi, G. N.
    Mauro, D.
    Pusztai, L.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (02) : 619 - 627
  • [5] Retinoblastoma
    Dimaras, Helen
    Kimani, Kahaki
    Dimba, Elizabeth A. O.
    Gronsdahl, Peggy
    White, Abby
    Chan, Helen S. L.
    Gallie, Brenda L.
    [J]. LANCET, 2012, 379 (9824) : 1436 - 1446
  • [6] Gorelov A. I., 2014, Urologiya (Moscow), P54
  • [7] Gurevich P, 2001, ANTICANCER RES, V21, P1335
  • [8] The Fas signalling pathway and its role in the pathogenesis of cancer
    Houston, A
    O'Connell, J
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (04) : 321 - 326
  • [9] Fas ligand expression and depletion of T-cell infiltration in astrocytic tumors.
    Ichinose M.
    Masuoka J.
    Shiraishi T.
    Mineta T.
    Tabuchi K.
    [J]. Brain Tumor Pathology, 2001, 18 (1) : 37 - 42
  • [10] Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry
    Inwald, E. C.
    Klinkhammer-Schalke, M.
    Hofstaedter, F.
    Zeman, F.
    Koller, M.
    Gerstenhauer, M.
    Ortmann, O.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (02) : 539 - 552